J&J's nasal antidepressant heads for FDA panel - FierceBiotech

Submitted by Anonymous (not verified) on Mon, 02/11/2019 - 15:35

J&J's nasal antidepressant heads for FDA panel  FierceBiotechJohnson & Johnson's new antidepressant esketamine comes in front of an FDA advisory committee tomorrow, hoping to end a drought in novel therapies for the ...